about
Regulation of cardiac bradykinin B1- and B2-receptor mRNA in experimental ischemic, diabetic, and pressure-overload-induced cardiomyopathy.Nerve growth factor promotes cardiac repair following myocardial infarction.Cardioprotective mechanisms of the kallikrein-kinin system in diabetic cardiopathy.Apolipoprotein A-I gene transfer exerts immunomodulatory effects and reduces vascular inflammation and fibrosis in ob/ob mice.Reversible transition from a hypertrophic to a dilated cardiomyopathy.High-density lipoprotein at the interface of type 2 diabetes mellitus and cardiovascular disorders.Cardiac effects of HDL and its components on diabetic cardiomyopathy.Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.Down-regulation of endothelial TLR4 signalling after apo A-I gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammation.Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene.Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection.Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy.Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy.[Cardiovascular risk of androgen deprivation therapy for treatment of hormone-dependent prostate cancer : Differences between GnRH antagonists and GnRH agonists].LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.Impact of HDL on adipose tissue metabolism and adiponectin expression.The cardiovascular influence of interleukin-1 beta on the expression of bradykinin B1 and B2 receptors.Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardium.AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats.Cardiac kinin level in experimental diabetes mellitus: role of kininases.Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction.Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene.Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis.Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor.Human Endomyocardial Biopsy Specimen-Derived Stromal Cells Modulate Angiotensin II-Induced Cardiac Remodeling.The angiotensin-(1-7) receptor agonist AVE0991 is cardioprotective in diabetic rats.Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy.Protection against oxidative stress in diabetic rats: role of angiotensin AT(1) receptor and beta 1-adrenoceptor antagonism.Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy.Human adult skeletal muscle stem cells differentiate into cardiomyocyte phenotype in vitro.Role of left ventricular stiffness in heart failure with normal ejection fraction.Cardiac contractility modulation signals improve exercise intolerance and maladaptive regulation of cardiac key proteins for systolic and diastolic function in HFpEF.Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage.High-density lipoproteins reduce palmitate-induced cardiomyocyte apoptosis in an AMPK-dependent manner.High-density lipoproteins reduce endothelial-to-mesenchymal transition.Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy.Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction.Upregulation of the cardiac bradykinin B2 receptors after myocardial infarction.Myocardial bradykinin B2-receptor expression at different time points after induction of myocardial infarction
P50
Q30875948-B923AE54-F3CB-431D-9547-0217BC618A42Q33894861-DC37E55B-2E19-46E9-B35D-1502E250C382Q36337788-2AE67CE0-8D2D-4CFF-AA7B-FB554514E442Q37145156-2D13BD37-E339-419C-9B69-86ABCF0699C8Q37340481-B1458883-1A58-4691-BD8C-2EC8AA40F00CQ37701507-2F9950E7-074E-493E-B187-37DA69727C47Q37974941-9C9E5229-7ABD-43A0-A17F-0E8413F2F133Q38895571-C26B6CFB-A472-440D-A00A-97AEE8E129B4Q39640351-921AA968-4AF8-4D10-BCE4-9FD7546FA993Q39683645-37A142DC-8731-4161-B69D-E16012B26D8FQ39738999-259C616D-86CF-4032-8B00-37994B7AE463Q39802111-98B14D23-8061-4C33-84B5-6D00535404BBQ39815739-6C60D184-375B-4A68-84DB-5AB00C8144C0Q40797796-496ED1CE-BC53-4A2C-928F-19626AEEF345Q42452072-2F6485F6-4ED5-45D3-8C11-82D953C9028EQ42468176-EEC783D9-8602-4108-8092-323F53544783Q42523401-724546EC-CD7D-46B4-A680-E86E0B5B76B9Q43655496-AA253551-3762-4E22-AFF9-8138816CE81EQ44086912-42E17807-C4B4-4D74-8F20-DDE7AFC2919AQ44362060-459BBDE1-004D-4811-908B-918E098D1842Q44883730-B4F365FB-99C8-4B11-B600-CF0C2C603C89Q45077988-63836842-FEDD-4242-B42A-C49A6D543B7AQ45855269-56EC04E9-9EFC-4955-AA0B-2BD8CA4B903AQ46094209-04C47692-8E3A-4BD6-B291-29D938DAFD90Q46510689-B247DDE3-5BC9-4CF4-BE2D-31E610A91A1AQ46525929-059FDE54-F546-429A-879B-F1A829EDA100Q46675928-C84D8B88-83ED-4564-917C-36D5378C1C83Q46684053-D98EBDCD-F56F-4E9C-BE03-0D8C166F6768Q46708859-8FCA7798-E269-433F-8D56-C2A970845131Q46987393-5FF58FE7-9509-4EF5-A856-EA7915CC2D91Q47772117-310E8A60-7F16-4F82-9DDB-16EA80B53B63Q47891501-94A6FAA6-3DC5-4669-A682-165136EA7064Q52565046-453A71D1-5704-4608-B37F-8EB96314011DQ52862453-28882D70-381E-47A7-8721-E561D1C0DBCEQ52865312-C5986EC5-1361-45B6-BA2A-A51944A2736CQ52926321-A1FFA715-F8DB-47B4-8C68-4A1B7009F915Q52930017-2F1C589A-A686-4A22-8AFA-E62BD3940A92Q52975230-2BB955DC-9B78-4DFF-99A3-7343BEC1CA35Q56963692-3EAA790A-3744-4AE4-A532-C33F87D3368F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Frank Spillmann
@ast
Frank Spillmann
@en
Frank Spillmann
@es
Frank Spillmann
@nl
Frank Spillmann
@sl
type
label
Frank Spillmann
@ast
Frank Spillmann
@en
Frank Spillmann
@es
Frank Spillmann
@nl
Frank Spillmann
@sl
prefLabel
Frank Spillmann
@ast
Frank Spillmann
@en
Frank Spillmann
@es
Frank Spillmann
@nl
Frank Spillmann
@sl
P106
P108
P21
P31
P496
0000-0003-0002-5745